AFP and hepatocellular carcinoma: Alpha-fetoprotein (AFP), together with hepatic ultrasonography, is the most common marker used in clinical practice to detect HCC in cirrhotic patients, and has been considered the gold-standard serum marker for screening patients at high risk for HCC, as well as for the diagnosis and monitoring of responses to HCC treatment for over 40 years.